河南预防医学杂志2024,Vol.35Issue(1) :1-5.DOI:10.13515/j.cnki.hnjpm.1006-8414.2024.01.002

2021年河南省1 277株结核分枝杆菌耐药特征分析

Drug resistance characteristics of 1 277 isolates of Mycobacterium tuberculosis in Henan province in 2021

朱岩昆 苏茹月 常文静 张雅兰 马晓光 郑丹薇 王少华 石洁 孙国清 孙定勇
河南预防医学杂志2024,Vol.35Issue(1) :1-5.DOI:10.13515/j.cnki.hnjpm.1006-8414.2024.01.002

2021年河南省1 277株结核分枝杆菌耐药特征分析

Drug resistance characteristics of 1 277 isolates of Mycobacterium tuberculosis in Henan province in 2021

朱岩昆 1苏茹月 1常文静 1张雅兰 2马晓光 1郑丹薇 1王少华 1石洁 1孙国清 1孙定勇1
扫码查看

作者信息

  • 1. 河南省疾病预防控制中心,河南郑州 450016;河南省结核病参比医学重点实验室
  • 2. 河南省疾病预防控制中心,河南郑州 450016;河南省传染病病原生物重点实验室
  • 折叠

摘要

目的 了解河南省结核分枝杆菌耐药特征,为结核病临床治疗和防控提供数据支持.方法 收集2021年河南省30个县(市、区)初诊涂阳肺结核患者分离鉴定的结核分枝杆菌,采用结核分枝杆菌比例法固体药敏试验法,开展对异烟肼(INH)、利福平(RFP)、链霉素(SM)、乙胺丁醇(EMB)、氧氟沙星(OFX)、左氧氟沙星(LFX)、卡那霉素(KM)、莫西沙星(MFX)、阿米卡星(AM)9种抗结核药物的敏感性试验并分析耐药性.结果 共获得结核分枝杆菌1 277株,总耐药率23.88%(305株)、单耐药率11.35%(145株)、耐多药率5.17%(66株)、多耐药率7.36%(94株)、准广泛耐药率0.47%(6株)、广泛耐药率0.31%(4株);结核分枝杆菌耐一线药物最高为SM(14.72%,188株)、其次为INH(12.53%,160株),耐二线药物最高为OFX(5.4%,69株)、其次为LFX(4.23%,54株);从初治肺结核患者分离结核分枝杆菌对9种药物的耐药率均低于复治患者(P均<0.05).66株耐多药结核分枝杆菌的耐药谱中占比最高的前3种是 RFP+INH+SM(12.12%,8 株)、RFP+INH+EMB+SM(27.27%,18 株)和 RFP+INH+EMB+SM+OFX+LFX+MFX(21.21%,14株);SM与AM(KM)存在单向交叉耐药,AM与KM存在低度双向交叉耐药情况,MFX、LFX与OFX存在相互交叉耐药情况.结论 河南省结核分枝杆菌总耐药、耐多药以及喹诺酮类药物的耐药情况仍较为严重,应积极采取措施以降低耐药率及减少耐药结核病的传播.

Abstract

Objective To understand the drug resistance characteristics of Mycobacterium tuberculosis in Henan province,and provide data support for the clinical treatment and prevention of tuberculosis.Methods Mycobacterium tuberculosis(M.tuberculosis)isolates from newly diagnosed smear-positive pulmonary tuberculosis patients in 30 counties(cities and districts)of Henan province in 2021 were collected.Drug susceptibility tests on 9 anti-tuberculosis drug[Isoniazid(INH),Rifampicin(RFP),Streptomycin(SM),Ethambutol(EMB),Ofloxacin(OFX),Kanamycin(KM),Moxifloxacin(MFX),Levofloxacin(LFX),Amikacin(AM)]were conducted using the proportion method based on the solid medium,and the drug resistance was analyzed.Results A total of 1 277 isolates of M.tuberculosis were collected,with an overall drug resistance rate of 23.88%(305/1 277),single drug resistance rate of 11.35%(145/1 277),multi-drug resistance rate of 5.17%(66/1 277),poly-drug resistance rate of 7.36%(94/1 277),pre-extensive resistance rate of 0.47%(6/1 277)and extensive resistance rate of 0.31%(4/1 277).The highest resistant rate of M.tuberculosis to first-line drugs was SM(14.72%,188/1 277),followed by INH(12.53%,160/1 277);the highest resistant rate of M.tuberculosis to second-line drugs was OFX(5.4%,69/1 277),followed by LFX(4.23%,54/1 277).M.tuberculosis isolates from initially-treated tuberculosis patients had lower resistant rate to the nine drugs tested than those from retreated patients(all P<0.05).Of the 66 multidrug-resistant isolates,the top three patterns with the highest proportions were RFP+INH+SM(12.12%,8/66),RFP+INH+EMB+SM(27.27%,18/66)and RFP+INH+EMB+SM+OFX+LFX+MFX(21.21%,14/66).There was single-directional cross-resistance between SM and AM(KM),and bidirectional cross-resistance at low concentration between AM and KM,and mutual cross-resistance between MFX,LFX and OFX.Conclusions The overall drug resistance,multidrug resistance and quinolone drug resistance of Mycobacterium tuberculosis in Henan province are still relatively serious,and active measures should be taken to reduce the drug resistance rate and the spread of drug-resistant tuberculosis.

关键词

结核分枝杆菌/耐药/交叉耐药

Key words

Mycobacterium tuberculosis/Drug resistance/Cross-resistance

引用本文复制引用

基金项目

河南省科技攻关项目(222102310726)

河南省医学科技攻关联合共建项目(LHGJ20230615)

出版年

2024
河南预防医学杂志
河南省预防医学会

河南预防医学杂志

影响因子:0.409
ISSN:1006-8414
被引量1
参考文献量10
段落导航相关论文